Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NMES and BCAA after living-donor liver transplantation
jRCTs071190051Completed
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of Branchamin in decompensated cirrhosis (2 arms). Primary endpoint: Change in skeletal muscle mass to day 90 post LDLT. Started Sep 2020; status: completed.
02
Drugs
Branchamin
03
Conditions
decompensated cirrhosis
Beyond the preview
Go deeper on jRCTs071190051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071190051.